14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

ZYNE Predictions History

2 years ago
kyle.cuschieri.17.239611 predicted that ZYNE for 2021-06-04 is going $10.00 (93.80%)

Rank:

2 years ago
JS predicted that ZYNE for 2021-05-28 is going $5.18 (-8.80%)

2 years ago
bizarreshadow1337.240487 predicted that ZYNE for 2021-05-28 is going

Rank:

2 years ago
imerk97.233207 predicted that ZYNE for 2021-05-28 is going

Rank:

2 years ago
JS predicted that ZYNE for 2021-05-26 is going $5.15 (-1.34%)

3 years ago
tobias140703.229699 predicted that ZYNE for 2021-04-21 is going $5.50 (24.72%)

Rank:

3 years ago
JS predicted that ZYNE for 2021-02-17 is going $6.04 (7.66%)

3 years ago
ranadheer30 predicted that ZYNE for 2021-02-17 is going $5.81 (3.57%)

Rank:

3 years ago
JS predicted that ZYNE for 2021-02-09 is going $5.37 (-9.82%)

3 years ago
Milan predicted that ZYNE for 2021-02-09 is going $5.80 (1.05%)

Rank:
Click to get the best stock tips daily for free!

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba P... ZYNE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT